Protocol Ledger

NCT04110054 · Phase II · COMPLETED

Evaluation of S-600918 in Adults With Refractory Chronic Cough

Interventional Phase II clinical trial protocol NCT04110054 sponsored by Shionogi in Respiratory and Pulmonary, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-02-13 Enrollment: 406 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04110054
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)406 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04110054
Protocol FieldVerified Registry Value
NCT IdentifierNCT04110054
Consolidated Lead SponsorShionogi
Therapeutic Condition CohortRespiratory and Pulmonary
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment406 participants (ACTUAL)
Registered Start Date2020-02-13
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI